Roivant Sciences (ROIV) Exchange Rate Effect (2023 - 2025)
Roivant Sciences (ROIV) posted Exchange Rate Effect of $2.5 million for Q4 2025, up 103.23% on a QoQ basis from $1.2 million in Q3 2025, and up 98.3% year-over-year from $1.2 million in Q4 2024.
Roivant Sciences (ROIV) Exchange Rate Effect (2023 - 2025) Analysis & Trends
Roivant Sciences' Exchange Rate Effect history runs 3 years deep, the most recent figure standing at $2.5 million for Q4 2025.
- Quarterly Exchange Rate Effect rose 98.3% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.7 million (up 13.93% YoY) and the FY2026 annual result came in at $3.8 million, up 404.28% from the prior year.
- Exchange Rate Effect was $2.5 million for Q4 2025 at Roivant Sciences, up from $1.2 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $5.0 million in Q3 2024 and bottomed at -$2.7 million in Q2 2024.
- A 3-year average of $879000.0 and a median of $1.2 million in 2025 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 446.84% in 2024, while the deepest fall reached 2241.88% in 2024.
- Roivant Sciences' Exchange Rate Effect stood at $1.5 million in 2023, then dropped by 15.98% to $1.2 million in 2024, then surged by 98.3% to $2.5 million in 2025.
- Business Quant data shows ROIV's Exchange Rate Effect at $2.5 million in Q4 2025, $1.2 million in Q3 2025, and $815000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.45 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 815,000.00 |
| Jun 30, 2025 | 815,000.00 |
| Dec 31, 2024 | 1.24 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 5.04 Mn |
| Sep 30, 2024 | 5.04 Mn |
| Jun 30, 2024 | -2.74 Mn |
| Jun 30, 2024 | -2.74 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | -1.45 Mn |
| Sep 30, 2023 | -1.45 Mn |
| Jun 30, 2023 | -117,000.00 |
| Jun 30, 2023 | -117,000.00 |